U.S. Markets open in 7 hrs 49 mins

Strength Seen in Alkermes (ALKS): Stock Up 8.5%

Zacks Equity Research

Alkermes plc (ALKS) was a big mover last session, as the company saw its shares surge by about 8.5% on the day. The move came on solid volume too, with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $30.17 to $35.21 in the past one-month time frame.

The company has seen no estimate revision in the past 2 months. Moreover, its earnings consensus has remained stagnant over the same time frame. However, this recent price action is certainly encouraging, so make sure to keep a close watch of this firm in the near future.

ALKS currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better performing med-biomed/gene stocks include Actelion Ltd. (ALIOF), AMAG Pharmaceuticals, Inc. (AMAG) and Gentium S.p.A (GENT). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Read the Full Research Report on ALKS
Read the Full Research Report on ALIOF
Read the Full Research Report on AMAG
Read the Full Research Report on GENT

Zacks Investment Research